MAPT and Alzheimer disease: These inhibitors showed a time-dependent improvement in memory retention and dose-dependent attenuation of Aβ, tau phosphorylation, and inflammatory markers, and AD-associated proteins were decreased in the hippocampus following DPP-4is administration (Kosaraju et al., 2013b; Ma et al., 2018).